Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-18

Clinical Trial Update: Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tetrahydrobiopterin (sapropterin dihydrochloride) in adults with chronic kidney disease and albuminuria has completed and posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kuvan (sapropterin dihydrochloride) (sapropterin dihydrochloride)

Snippet

Sponsor: University of Michigan | Conditions: Kidney Disease, Albuminuria | Phase 2 | Status: COMPLETED | Results posted: 2016-10-18